fatigue; body aches; This is a spontaneous report from a contactable consumer (patient). A 77-years-old male patient received first dose of bnt162b2 (BNT162B2, lot # ELO142), via an unspecified route of administration on 09Jan2021 at single dose for covid-19 immunisation. Medical history included hypertension, diabetes and pacemaker. The patient's concomitant medications were not reported. The patient experienced fatigue and body aches on day of injection on 09Jan2021. The event outcome was unknown.